Septerna (SEPN) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Septerna Inc is developing a breakthrough Native GPCR system to create drugs for immune pathologies. The startup's success relies on the confirmed effectiveness of its platform and interest from funds. The company's EV/EBITDA multiple visualizes these expectations, where the 0.00 figure denotes the current asset valuation level. The firm's environmental strategy is limited to standard laboratory waste disposal.
septerna.com - analytical breakdowns and key metrics (SEPN)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
SEPN - Profit After Tax|Future Profit Septerna Inc|SEPN - Market Price to Net Income Ratio|Forward P/E Multiple Septerna Inc|SEPN - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Septerna Pharma|SEPN - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Septerna|SEPN - Earnings per share for the last 12 months|Quarterly EPS earnings growth septerna.com|SEPN - Earnings growth in current year|Expected earnings per share growth for next year Septerna Inc
Initial company analysis:SEPN (Septerna Corp)
Septerna Inc (SEPN) operates high-tech robotic laboratories with assets in pristine condition, which necessitates accounting for the cost of capital during valuation. The company's EV/EBITDA ratio, accounting for debt load, aggregates market value and debt, benchmarking them against operating profit before depreciation and amortization. Analyzing the dynamics of this metric allows investors to determine the fair value of the business, eliminating emotional decision-making when interpreting the trend.
Analysis of competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|VERA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Dianthus Corp DNTH|PHVS: EV/EBITDA Multiple|Company Value to EBITDA AbCellera (ABCL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Precigen Inc - Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio PHAR (Pharming)|Enterprise Value to Operating Income Before Depreciation Ratio NKTR|EV/EBITDA Multiple UPB (Upstream Bio Inc)|zenasbio.com (ZBIO) - Company Value to EBITDA|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation GOSS (Gossamer Bio Inc)|KalVista Pharmaceuticals Inc (KALV) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation PVLA|SVRA (Savara Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple rigel.com|Enterprise Value to EBITDA Ratio ANAB (AnaptysBio)|ATXS (Astria Therapeutics Inc) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ENGN (enGene Bio)|Total Company Value to Operating Income Before Depreciation Ratio rapt.com (RAPT)|JBIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACRS (aclaristx.com) - Enterprise Value to Operating Income Before Depreciation|KYTX: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Tiziana Life Sciences Ltd.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cabaletta Bio, Inc|Ventyx Biosciences, Inc (VTYX) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple THTX|AVTX - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Eledon Pharmaceuticals, Inc. ELDN|AGEN (Agenus, Inc.) - Company Value to Operating Income Before Depreciation Ratio|CLYM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ZURA (zurabio.com) - Enterprise Value to Operating Income Before Depreciation|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ADAG (Adagene Inc.)|IMA (ImageneBio) - EV/EBITDA Multiple|STTK: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple EQ|EV/EBITDA Multiple connectbiopharm.com (CNTB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|Business Value to Operating Income Before Depreciation ATRA|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|X4 Pharmaceuticals Inc. (XFOR) - Enterprise Value to EBITDA Ratio|ACET: EV/EBITDA Multiple|Celularity (CELU) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio INMB|BRNS: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple KZR|Total Company Value to Operating Income Before Depreciation Ratio SAB Biotherapeutics Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akari Therapeutics plc AKTX|ENLV - Enterprise Value to EBITDA Ratio|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|geovax.com (GOVX) - Enterprise Value to EBITDA Ratio|EDSA (Edesa Biotech) - Enterprise Value to EBITDA Ratio|iBio Inc (IBIO) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to Operating Income Before Depreciation XTLB (XTL Bio)|EV/EBITDA Multiple BOLT|HCWB - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|Total Company Value to Operating Income Before Depreciation Ratio aimimmuno.com (AIM)|Aditxt Corp - EV/EBITDA Multiple|Company Value to EBITDA GRI Bio Corporation|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio HIND (reshapelifesciences.com)|Enterprise Value to EBITDA Ratio REVB|INDP (Indaptus Therapeutics Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SCNI|CALI - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|Business Value to Operating Income Before Depreciation ALLK|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IGMS (IGM Biosciences, Inc.) - Enterprise Value to Operating Income Before Depreciation|ITOS: EV/EBITDA Multiple|Ocean Biomedical Corp (OCEA) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio TCBP|THRD: Business Value to Operating Income Before Depreciation
